JT

John C. Timmer

IN Inhibrx: 6 patents #1 of 18Top 6%
IB Inhibrx Biosciences: 2 patents #1 of 9Top 15%
📍 Village of La Jolla, CA: #10 of 418 inventorsTop 3%
🗺 California: #1,951 of 67,048 inventorsTop 3%
Overall (2024): #14,265 of 561,600Top 3%
8
Patents 2024

Issued Patents 2024

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12084502 CD33-binding polypeptides and uses thereof Kyle S. Jones, William Crago, Angelica Sanabria, Andrew Hollands, Jacob Gano +2 more 2024-09-10
12043667 CLEC12a binding polypeptides and uses thereof Lucas Rascon, Angelica Sanabria, Brendan P. Eckelman 2024-07-23
12012459 OX40-binding polypeptides and uses thereof William Crago, Kyle S. Jones, Katelyn M. Willis, Florian Sulzmaier, Bryan Becklund +1 more 2024-06-18
11976126 Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells Kyle S. Jones, Amir S. Razai, Abrahim Hussain, Katelyn M. Willis, Quinn Deveraux +1 more 2024-05-07
11965017 Serpin fusion polypeptides and methods of use thereof Brendan P. Eckelman, Peter L. Nguy, Grant B. Guenther, Quinn Deveraux 2024-04-23
11945869 PD-1 single domain antibodies and therapeutic compositions thereof Rajay Pandit, Angelica Sanabria, Florian Sulzmaier, Brendan P. Eckelman 2024-04-02
11919963 CD123-binding polypeptides and uses thereof Chelsie Macedo, Kyle S. Jones, William Crago, Andrew Hollands, Milton Ma +1 more 2024-03-05
11866507 Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same Brendan P. Eckelman, Michael D. KAPLAN, Katelyn M. Willis, Quinn Deveraux 2024-01-09